首页 > 市场调查报告书 > 製药

感染疾病

市场调查报告书

商品编码

1705801

全球香港脚市场按疾病类型、治疗类型、给药途径、分销管道和地区划分

Global Athlete's Foot Market, By Disease Type, By Treatment Type, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2025年03月04日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球香港脚市场规模估计为 14.1 亿美元，预计到 2032 年将达到 19.9 亿美元，2025 年至 2032 年的复合年增长率为 5.0%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	14.1亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	5.00%	2032年价值预测	19.9亿美元

数字。 2025年全球市场占有率香港脚市占率（按地区）

香港脚，也称为香港脚，是一种常见的真菌感染疾病，会影响足部皮肤，尤其是脚趾之间的皮肤，但也会扩散到脚趾甲和手部。这种真菌在温暖、潮湿的环境中茁壮成长，例如运动员常见的汗湿鞋子内，因此得名香港脚。这种病症的特征是脚趾之间和脚底有搔痒、刺痛和灼热感。受影响区域的皮肤可能会变红、脱皮、破裂或起水泡。虽然这是一种令人不快的疾病，但通常症状较轻，可以用非处方抗真菌药物治疗。对于持续或严重的情况，可能需要更强的处方笺治疗。香港脚是由皮癣菌（一种生长在皮肤死皮外层的真菌）引起的。这种真菌很容易透过直接接触受污染的表面或间接接触毛巾、鞋子或衣服来传播。公共淋浴设备、游泳池和更衣室是病毒传播的热点，运动员和健身者尤其容易受到感染。足部卫生在预防香港脚中扮演重要角色。这包括保持双脚清洁干燥、穿透气的鞋子、定期更换袜子，以及不要在可能存在真菌的公共场所赤脚行走。患有香港脚的人也应注意不要将感染传播到身体的其他部位或其他人。早期发现和治疗香港脚非常重要，以防止感染疾病变得难以控制并导致更严重的继发性细菌感染。了解原因、预防和治疗方法可以帮助您有效地控制这种情况并保持足部健康。

市场动态：

全球香港脚市场受到感染疾病上升的推动，这主要是由于老年人口的增长、肥胖率的上升以及水上运动参与度的增加。人们对未治疗的足部真菌感染疾病的影响的健康意识的提高也推动了自我诊断和非处方药物治疗。然而，替代治疗方案，例如使用非处方（OTC）外用药膏和粉剂的家庭疗法，可能会阻碍处方药的产生收入潜力。

本研究的主要特点

本报告对全球香港脚市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模和年复合成长率(CAGR)。
它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
全球香港脚市场的主要企业简介是根据公司亮点、产品系列、关键亮点、财务业绩和策略等参数列出的。
本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球香港脚市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
相关人员将透过用于分析全球香港脚市场的各种策略矩阵更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 1.41 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.00%	2032 Value Projection:	USD 1.99 Bn

Athlete's foot, also known as tinea pedis, is a common fungal infection that affects the skin on the feet, particularly the spaces between the toes, but can also spread to the toenails and hands. It is named athlete's foot because it is frequently seen in athletes, as the fungus thrives in warm, moist environments, such as the inside of sweaty shoes, which are common among sports participants. This condition is characterized by itching, stinging, and burning sensations between the toes or on the soles of the feet. The affected skin may also become red, flaky, cracked, or blistered. Although the condition can be uncomfortable, it is generally mild and can be treated with over-the-counter antifungal medications. In persistent or severe cases, prescription-strength treatments may be necessary. Athlete's foot is caused by dermatophytes, a type of fungus that grows on the dead outer layer of skin. The fungus spreads easily through direct contact with contaminated surfaces or through indirect contact with towels, shoes, or clothing. Communal showers, swimming pools, and locker rooms are hotspots for transmission, making athletes and gym-goers particularly susceptible. Good foot hygiene plays a crucial role in preventing athlete's foot. This includes keeping the feet clean and dry, wearing breathable footwear, changing socks regularly, and avoiding walking barefoot in public places where the fungus may be present. Individuals with athlete's foot should also be careful not to spread the infection to other parts of their body or to other people. Early detection and treatment of athlete's foot are important to prevent the infection from becoming more difficult to manage or leading to more serious secondary bacterial infections. Understanding the causes, prevention, and treatment options enables individuals to effectively deal with this condition and maintain good foot health.

Market Dynamics:

The global athlete's foot market is primarily driven by the rising prevalence of the infection due to a growing geriatric population, increasing obesity rates, and greater participation in aquatic activities. Growing health awareness regarding implications of untreated fungal infections of feet is also supporting self-diagnosis and over-the-counter medication. However, alternative treatment options such as home remedies using over-the-counter (OTC) topical creams and powders may hinder revenue generation potential for prescription drugs.

Key features of the study:

This report provides in-depth analysis of the global athlete's foot market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global athlete's foot market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Perrigo Company Plc., Novartis AG, Valeant Pharmaceuticals International, GlaxoSmithKline plc, Bayer AG, Teva Pharmaceuticals Industries Ltd., Mylan NV, Glenmark Pharmaceutical Ltd, Taro Pharmaceutical Industries Ltd., Camber Pharmaceuticals Inc, Aurobindo Pharma Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global athlete's foot market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global athlete's foot market

Detailed Segmentation:

Global Athlete's Foot Market, By Drug Class
- Antifungals
- Combination
Global Athlete's Foot Market, By Disease Indication
- Interdigital
- Plantar
- Vesicular
Global Athlete's Foot Market, By Route of Administration
- Topical
- Oral
Global Athlete's Foot Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Athlete's Foot Market, By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Perrigo Company Plc.
- Novartis AG
- Valeant Pharmaceuticals International
- GlaxoSmithKline plc
- Bayer AG
- Teva Pharmaceuticals Industries Ltd.
- Mylan NV
- Glenmark Pharmaceutical Ltd
- Taro Pharmaceutical Industries Ltd.
- Camber Pharmaceuticals Inc
- Aurobindo Pharma Ltd

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Athlete's Foot, By Drug Class
- Market Athlete's Foot, By Disease Indication
- Market Athlete's Foot, By Route of Administration
- Market Athlete's Foot, By Distribution Channel
- Market Athlete's Foot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
Growing health and hygiene awareness
Increasing spending on personal care and sports healthcare
Technological advancements in treatment options
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Athlete's Foot Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Athlete's Foot Market, By Drug Class, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Antifungals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Combination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Athlete's Foot Market, By Disease Indication, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Interdigital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Plantar
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Vesicular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Athlete's Foot Market, By Route of Administration, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Segment Trends
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Athlete's Foot Market, By Distribution Channel, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global Athlete's Foot Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2020 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Company Profile
- Perrigo Company Plc.
Drug Class Portfolio
Key Developments
Financial Performance
Strategies
- Novartis AG
Drug Class Portfolio
Key Highlights
Financial Performance
Strategies
- Valeant Pharmaceuticals International
Drug Class Portfolio
Key Highlights
Financial Performance
Strategies
- GlaxoSmithKline plc
Company Highlights
Drug Class Portfolio
Key Highlights
Financial Performance
Strategies
- Bayer AG
Company Highlights
Drug Class Portfolio
Key Highlights
Financial Performance
Strategies
- Teva Pharmaceuticals Industries Ltd.
Company Highlights
Drug Class Portfolio
Key Highlights
Financial Performance
Strategies
- Mylan NV
Company Highlights
Drug Class Portfolio
Key Highlights
Financial Performance
Strategies
- Glenmark Pharmaceutical Ltd
Company Highlights
Drug Class Portfolio
Key Highlights
Financial Performance
Strategies
- Taro Pharmaceutical Industries Ltd.
Company Highlights
Drug Class Portfolio
Key Highlights
Financial Performance
Strategies
- Camber Pharmaceuticals Inc
Company Highlights
Drug Class Portfolio
Key Highlights
Financial Performance
Strategies
- Aurobindo Pharma Ltd
Company Highlights
Drug Class Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views

11. Section

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

全球香港脚市场按疾病类型、治疗类型、给药途径、分销管道和地区划分